{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T07:05:45Z","timestamp":1762067145112},"reference-count":57,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":10139,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[1979,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The effects of chronic administration of clorgyline and pargyline on rat brain monoamine metabolism have been examined. The inhibitory selectivity of these drugs towards serotonin deamina\u2010tion (MAO type A) and phenylethylamine deamination (MAO type B) can be maintained over a 21\u2010day period by proper selection of low doses of these drugs (0.5\u20101.0 mg\/kg\/24h). The results are consistent with MAO type A catalyzing the deamination of serotonin and norepinephrine and with MAO type B having little effect on these monoamines. Dopamine appears to be dcaminated <jats:italic>in vivo<\/jats:italic> principally by MAO type A. Clorgyline administration during a 3\u2010week period was accompanied by persistent elevations in brain norepinephrine concentrations; serotonin levels were also increased during the first 2 weeks, but returned towards control levels by the third week of treatment. Low doses of pargyline did not increase brain monoamine concentrations, but treatment with higher doses for 3 weeks led to elevations in brain norepinephrine and 5\u2010hydroxytryptamine; at this time significant MAO\u2010A inhibition had developed. The changes in monoamine metabolism seen at the end of the chronic clorgyline regimen are not due to alterations in tryptophan hydroxylase activity. At this time tyrosine hydroxylase activity was also unaffected.<\/jats:p>","DOI":"10.1111\/j.1471-4159.1979.tb04508.x","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T09:16:50Z","timestamp":1160039810000},"page":"49-55","source":"Crossref","is-referenced-by-count":102,"title":["THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAIN"],"prefix":"10.1111","volume":"32","author":[{"given":"I. C.","family":"Campbell","sequence":"first","affiliation":[]},{"given":"D. S.","family":"Robinson","sequence":"additional","affiliation":[]},{"given":"W.","family":"Lovenberg","sequence":"additional","affiliation":[]},{"given":"D. L.","family":"Murphy","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(68)90351-5"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1976.tb06967.x"},{"key":"e_1_2_2_4_1","first-page":"3","article-title":"Long\u2010lasting selective depletion of brain by 5,6\u2010dihydroxytryptamine","volume":"373","author":"Baumgarten H. G.","year":"1971","journal-title":"Acta physiol. scand. Suppl."},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1973.tb04246.x"},{"key":"e_1_2_2_6_1","first-page":"82","article-title":"Identification and assay of serotonin in brain","volume":"117","author":"Bogdanski D. F.","year":"1956","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00414411"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(75)90238-1"},{"issue":"2","key":"e_1_2_2_9_1","first-page":"14","article-title":"Effects of chronic regimes of phenelzine, tranylcypromine and imipramine on rat brain and 5\u2010hydroxytryptamine","volume":"5","author":"Campbell I. C.","year":"1974","journal-title":"J. Pharmac."},{"key":"e_1_2_2_10_1","first-page":"629","volume-title":"Proc. of Xth Congress of the CINP","author":"Campbell I. C","year":"1977"},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1972.tb05136.x"},{"issue":"3","key":"e_1_2_2_12_1","first-page":"539","article-title":"Studies on the functional role of intraneuronal monoamine oxidase. J","volume":"187","author":"Clarke D. E.","year":"1973","journal-title":"Pharmac. exp. Ther."},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(69)90163-0"},{"key":"e_1_2_2_14_1","volume-title":"Advances in Biochemical Psychopharmacology","author":"Costa E.","year":"1972"},{"key":"e_1_2_2_15_1","doi-asserted-by":"crossref","unstructured":"DonnellyC. H.(1977)Substrate\u2010 and inhibitor\u2010related characteristics of monoamine oxidase.Ph.D. Thesis University of Maryland.","DOI":"10.1016\/0006-2952(77)90398-7"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(77)90398-7"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90476-7"},{"key":"e_1_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90512-8"},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90359-2"},{"key":"e_1_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.178.4059.414"},{"key":"e_1_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)45055-2"},{"key":"e_1_2_2_22_1","first-page":"341","article-title":"Brain serotonin, affective illness, and antidepressant drugs: Cerebrospinal fluid studies with probenecid","volume":"11","author":"Goodwin F. K.","year":"1974","journal-title":"Biochem. Psychopharmac."},{"key":"e_1_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1971.tb12034.x"},{"key":"e_1_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1973.tb00288.x"},{"key":"e_1_2_2_25_1","first-page":"163","volume-title":"Advances in Biochemical Psychopharmacology","author":"Hery R.","year":"1974"},{"key":"e_1_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(68)90066-X"},{"key":"e_1_2_2_27_1","first-page":"344","article-title":"Enzymic studies on the metabolism of 5\u2010hydroxyindoles in the brain","volume":"29","author":"Kido R.","year":"1975","journal-title":"Acta Vitam. Enzym."},{"key":"e_1_2_2_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.180.4086.645"},{"key":"e_1_2_2_29_1","first-page":"812","article-title":"Effects of lithium chloride on parameters of biosynthetic capacity for 5\u2010hydroxytryptamine in rat brain","volume":"193","author":"Knapp S.","year":"1975","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_2_30_1","first-page":"393","volume-title":"Advances in Biochemical Psychopharmacology","author":"Knoll J.","year":"1972"},{"key":"e_1_2_2_31_1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0021-9258(18)64137-7","article-title":"The metabolic fate of [3H]\u2010epinephrine and [14C]\u2010metanephrme in the rat","volume":"236","author":"Kopin I. J.","year":"1961","journal-title":"J. biol. Chem."},{"key":"e_1_2_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(65)90693-8"},{"key":"e_1_2_2_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1971.tb11961.x"},{"key":"e_1_2_2_35_1","volume-title":"Neurobiological Mechanisms of Adaptation and Behavior","author":"Mandell A. J.","year":"1975"},{"key":"e_1_2_2_36_1","doi-asserted-by":"publisher","DOI":"10.1139\/o69-078"},{"key":"e_1_2_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(71)90155-9"},{"key":"e_1_2_2_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1972.tb08080.x"},{"key":"e_1_2_2_39_1","article-title":"Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man","author":"Murphy D. L.","journal-title":"Psychopharmacology"},{"issue":"1","key":"e_1_2_2_40_1","first-page":"110","article-title":"Modulation of brain tryptophan hydroxylase activity by brain tryptophan content","volume":"201","author":"Neckers L. M.","year":"1977","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_2_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1975.tb04362.x"},{"key":"e_1_2_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(68)90163-9"},{"key":"e_1_2_2_43_1","unstructured":"RobinsonD. S. CampbellI. C WalkerM. N. Lovenberg W.&Murphy D. L..Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain. (Submitted)."},{"key":"e_1_2_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(67)90040-8"},{"key":"e_1_2_2_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1972.tb01336.x"},{"key":"e_1_2_2_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1963.tb13329.x"},{"key":"e_1_2_2_47_1","first-page":"355","volume-title":"Monoamine Oxidase\u2014New Vistas. Advances in Biochemical Psychopharmacology","author":"Squires R. F.","year":"1972"},{"key":"e_1_2_2_48_1","first-page":"11","volume-title":"Monoamine Oxidase\u2014New Vistas. Advances in Biochemical Psychopharmacology","author":"Tipton K. F.","year":"1972"},{"key":"e_1_2_2_49_1","first-page":"177","article-title":"Application of steady state kinetics to the synthesis rate and turnover time of serotonin in the brain of normal and reserpine\u2010treated rats","volume":"153","author":"Tozer T. N.","year":"1966","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_2_50_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9258(18)66041-7","article-title":"The estimation of 5\u2010hydroxytryptaminc (serotonin) in biological tissues","volume":"215","author":"Udenfriend S.","year":"1955","journal-title":"J. biol Chem."},{"key":"e_1_2_2_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/257495a0"},{"key":"e_1_2_2_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1974.tb06891.x"},{"key":"e_1_2_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00506483"},{"key":"e_1_2_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90525-7"},{"key":"e_1_2_2_55_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.10.040170.001421"},{"key":"e_1_2_2_56_1","first-page":"733","article-title":"The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines","volume":"189","author":"Yang H.\u2010Y. T.","year":"1974","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_2_57_1","first-page":"67","volume-title":"Advances in Biochemical Psychopharmacology","author":"Youdim M. B. H.","year":"1972"},{"key":"e_1_2_2_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a070980"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.1979.tb04508.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.1979.tb04508.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T19:11:48Z","timestamp":1699125108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.1979.tb04508.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1979,1]]}},"alternative-id":["10.1111\/j.1471-4159.1979.tb04508.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.1979.tb04508.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,1]]}}}